CN1159488C - Antibacterial flexible material containing nm silver and its preparing process and application - Google Patents
Antibacterial flexible material containing nm silver and its preparing process and application Download PDFInfo
- Publication number
- CN1159488C CN1159488C CNB01102268XA CN01102268A CN1159488C CN 1159488 C CN1159488 C CN 1159488C CN B01102268X A CNB01102268X A CN B01102268XA CN 01102268 A CN01102268 A CN 01102268A CN 1159488 C CN1159488 C CN 1159488C
- Authority
- CN
- China
- Prior art keywords
- flexible material
- silver
- liquid
- material containing
- liters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000463 material Substances 0.000 title claims abstract description 51
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 38
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 36
- 239000004332 silver Substances 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title description 14
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000007788 liquid Substances 0.000 claims description 32
- 239000004744 fabric Substances 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 238000001035 drying Methods 0.000 claims description 25
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 13
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 13
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical class [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 3
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical group [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 abstract description 6
- 239000002245 particle Substances 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 229910001923 silver oxide Inorganic materials 0.000 abstract description 3
- 206010052428 Wound Diseases 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 2
- 206010040872 skin infection Diseases 0.000 abstract description 2
- 239000011882 ultra-fine particle Substances 0.000 abstract 2
- 208000014674 injury Diseases 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 239000002344 surface layer Substances 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 description 25
- 238000012360 testing method Methods 0.000 description 18
- 241000894006 Bacteria Species 0.000 description 17
- 239000004745 nonwoven fabric Substances 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 230000001954 sterilising effect Effects 0.000 description 9
- 238000005303 weighing Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 239000003112 inhibitor Substances 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 229920000742 Cotton Polymers 0.000 description 6
- 239000004753 textile Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 238000005238 degreasing Methods 0.000 description 5
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000012209 synthetic fiber Substances 0.000 description 4
- 229920002994 synthetic fiber Polymers 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 229920002972 Acrylic fiber Polymers 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 2
- 241000193468 Clostridium perfringens Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- -1 azoles quinoline furan oxime Chemical class 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 230000001408 fungistatic effect Effects 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- 241000589291 Acinetobacter Species 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 241000607522 Aeromonas sobria Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000222173 Candida parapsilosis Species 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- JFPVXVDWJQMJEE-QMTHXVAHSA-N Cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)C(=NOC)C1=CC=CO1 JFPVXVDWJQMJEE-QMTHXVAHSA-N 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 241001360526 Escherichia coli ATCC 25922 Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 229920004933 Terylene® Polymers 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 241000607265 Vibrio vulnificus Species 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 244000144987 brood Species 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229940055022 candida parapsilosis Drugs 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- RNQBLUNNAYFBIW-NPULLEENSA-M hexadecyl(trimethyl)azanium (2S)-2-(6-methoxynaphthalen-2-yl)propanoate Chemical compound COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O.CCCCCCCCCCCCCCCC[N+](C)(C)C RNQBLUNNAYFBIW-NPULLEENSA-M 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 1
- 229960001019 oxacillin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 229940046284 zinacef Drugs 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
Abstract
The present invention discloses a nano-silver antibacterial flexible material. Ultrafine particle silver is attached between the base units or on the base units of the flexible material, the surface layer of the ultrafine particle silver is silver oxide, the core is metal silver, and the particle size is from 1 to 900 nanometers. The flexible material can be used for daily use for people, can be used to treat skin infections and skin superficial mycotic infections for patients with traumas, and can be used as a functional yarn for preventing and treating the infections of incisional wounds after the incision operations of surgical operations.
Description
The invention relates to a kind of antiseptic flexible material and manufacture method thereof, more particularly, is about a kind of antibacterial flexible material containing nm silver and manufacture method and application.
Functional textile be this century the eighties at first propose by Germany scientist, and meet with a response in developed country rapidly, countries in the world have all been dropped into substantial contribution and have been researched and developed, and come out and are applied to clinical at portable existing procucts on the medicinal functional yarn of human body so far; But do not see breakthrough in the medicinal functional yarn of human body at Nonimplantation, the definition that main cause is to define this yarn must be carrier with the yarn, good stability, to the treatment of human body diseases ultra high efficiency, long-acting, low toxicity and auxiliary curing function or the like, the sort of anything but simple the sort of notion that sprinkles with the medicine dip-coating comes down to a kind of brand-new novel " stype ".
In the clear 54-151669 of Japan Patent, a kind of bactericidal properties cloth is disclosed, its compound resin solution independent or mixture that will contain copper, silver (6 microns of average grain diameters) is handled yarn, be made into bactericidal properties cloth again after making this solution evenly be coated on the surface of yarn, this product can be made the lining of rubber boot, canvas shoes and socks.
In Japan " process technology " vol.17 NO7 report, handle acrylic fiber with copper and sulfide, get acrylic fibers-copper sulfide compound, it has bacteriostasis to staphylococcus aureus, Escherichia coli, hay bacillus, the thread tinea alba bacterium of skin.
At Chinese invention patent CN87100231A, exercise question is " antibiotic odourproof fiber yarn and a manufacture method ", open day: disclose a kind of antimicrobial yarn in 18 days November in 1987, it is with acrylic fibers yarn priority and Cu+, Viride Nitens 4 composite crosslinkings, product has bacteria resistance function to 10 bacterial classifications such as staphylococcus aureus, MRSA, white Portugal coccus, Candida albicanss, and it can be used as underwear, socks, shoe-pad and the medical industry of antibacterial deodourizing, the Work Clothes of food industry.
In the flat 3-136649 of Japan Patent, the applying date: disclose a kind of anti-bacteria cloth that prevents mastitis for milk cows in 24 days October in 1989.It is compound with the coordinate bond form with silver ion and polyacrylonitrile, and product has inhibitory action to 6 kinds of bacterial classifications such as streptococcus, staphylococcus, can be used as the anti-bacteria cloth of wiping cow breast nipple with the mammitis of prevention milk cow.
More than these products antibacterial action is all arranged, but antimicrobial spectrum is wide, effect is not obvious, and different fully with the present invention.Antibacterial flexible material containing nm silver and manufacture method thereof and application
One of purpose of the present invention provides a kind of antibacterial flexible material containing and manufacture method thereof.
Two of purpose of the present invention provides a kind of antibacterial flexible material containing nm silver.
Three of purpose of the present invention provides a kind of manufacture method of antibacterial flexible material containing nm silver.
Four of purpose of the present invention provides a kind of application of antibacterial flexible material containing nm silver.
These and other objects of the present invention will and be described and further set forth by following detailed description.
In antibacterial flexible material containing nm silver of the present invention, be attached with ultra micron silver between the elementary cell of flexible material or on the elementary cell, the superficial layer of ultra micron silver is a silver oxide, and core is an argent, and its particle diameter is 1～900 nanometer; Between the elementary cell of flexible material or the amount of the ultra micron silver that adheres on the elementary cell be 2～200 micrograms/centimetre
2, described elementary cell can be between fiber, between yarn or absorption micropore etc.
In antibacterial flexible material containing nm silver of the present invention, described flexible material can be fabric, yarn or the textiles that synthetic fiber, natural fabric constitute, and also can be that paper or other have the synthetic or natural material of adsorptivity.Described natural fabric can be cotton, fiber crops, silk, wool fibre and other fiber, and synthetic fiber can be terylene, acrylic fibers, polyamide fibre and other fiber; Can or be made into textiles with above-mentioned synthetic fiber, natural fabric spun yarn, described textiles can be woven fabric, knitted fabric and bondedfibre fabric; The described synthetic or natural material that other has adsorptivity can be polymer adsorbing material such as sponge and inorganic mineral material, as zeolite, diatomite etc.
Further, antibacterial flexible material containing nm silver of the present invention, wherein flexible material is a bondedfibre fabric, this bondedfibre fabric can be made by natural or synthetic fiber, between the yarn of bondedfibre fabric or on be attached with ultra micron silver, the superficial layer of ultra micron silver is a silver oxide, and core is an argent, and its particle diameter is 1～900 nanometer; If necessary, on bondedfibre fabric, also contain liquid, amount of liquid is 20～200% of a bondedfibre fabric weight, the preferred liquid amount is 40～100% of a bondedfibre fabric weight, described liquid is the mixture of water, organic solvent and water and organic solvent, and water can be distilled water or other medically acceptable water, the monohydric alcohol of the preferred lower paraffin hydrocarbon of organic solvent, as ethanol etc., certain described liquid also can be other medically acceptable additive.
The preparation method of antibacterial flexible material containing nm silver of the present invention, comprise padding finishing liquid, roll steps such as dried, drying, described padding finishing liquid comprises that flexible material with marshalling in deflector roll is immersed in treatment fluid, keeps the liquid level certain height, and flexible material is fully soaked into.
Further, the preparation method of antibacterial flexible material containing nm silver of the present invention, also be included in drying, make the step that adds liquid behind the product, the amount of liquid of adding is 20～200% of a bondedfibre fabric weight, and the preferred liquid amount is 40～100% of a bondedfibre fabric weight.
In the preparation method of antibacterial flexible material containing nm silver of the present invention, dressing liquid contains: (in 200 kilograms of flexible materials)
4～32 kilograms of silver nitrates, 12～45 liters of ammoniacal liquor,
Add water to 1000 liters.
Further, in dressing liquid, can also be added with 1～25 kilogram of glucose.
In the preparation method of antibacterial flexible material containing nm silver of the present invention, dressing liquid can contain (in 200 kilograms of flexible materials):
4～32 kilograms of silver nitrates, 12～45 liters of ammoniacal liquor,
0.6～3.2 kilogram in NaOH, 0.2～11 kilogram of glucose,
0.1～0.6 liter in nitric acid, surplus are that water amounts to 1000 liters.
The preparation method of antibacterial flexible material containing nm silver of the present invention comprises that with flexible material padding finishing liquid, pick-up rate is 40～90%, under air blast and exhausting condition, use the hot air circulation drying then, time is 1～6 minute, and temperature is 90～180 ℃, and guarantees sufficient oxygen.
Antibacterial flexible material containing nm silver of the present invention can be used as medical (outward) material and the skin infection of treatment traumatic patient and the material of superficial skin fungus infection and prevention of surgical incision postoperative and treatment infection of incisional wound of treatment burn and scald; Also can be used as daily living article.
In the present invention, if necessary, the processing method of some textile industries, paper-making industry and polymer adsorbing material manufacturing industry and inorganic material manufacturing industry routine be can also add, pre-treatment, bulk processing, fine finishining, post-treating and other steps comprised; Can certainly comprise in conjunction with the conventional knowledge of this specialty and omit one or more steps by actual conditions, as long as but can prepare product.
The antifungal mechanism of product of the present invention is:
The nonactive enzyme of organized enzyme
Ag
+Sulfydryl-SH easy and in the electronegative bacterioprotein combines, the organized enzyme loss of activity that some bacteriums are depended on for existence, thus reach fungistatic effect.
In the present invention, according to classical theory, silver has bactericidal action preferably, and sterilization mechanism is:
Silver is more stable material, substantially water insoluble, and the sterilizing power of itself and antimicrobial spectrum were both so wideless so by force yet, this is bad solution in macrocosm, so must in the microcosmos of nano science, seek answer, be applied to clinical in treatment of diseases and the prevention.The Nano Silver technology is the product that is based upon on quantum chemistry, materials chemistry, the biochemistry three big basic subjects, by with the granular on the material yardstick of silver, makes it reach 10
-9The nanometer scale of rice, make full use of its skin effect, small-size effect and utilize various new specific physique and the effect that are different from macrocosm silver that it reflects, realize that it is long-lasting, broad spectrum activity, antibiotic strong, good stability, chance water effect not only do not weaken, the characteristic of Zeng Qianging and in killing the process of pathogenic bacteria on the contrary is not subjected to influence or the like the characteristic of human body acid-base degree.The penetrability of silver is strengthened simultaneously, promotes promoting regeneration of tissue for astringency, brings into play its treatment function.Because its surface area increases greatly, bigger variation also takes place in surface texture, and surface-activity strengthens greatly, and show high specific function, after testing, be 0.16～8.97 mg/ml to the MIC of pathogenic bacteria, MBC is 3.05～81.97 mg/ml, and its sterilizing ability has improved more than 200 times.
The nano-silver nonwoven cloth that applying nano silver fabrication techniques goes out is with a wide range of applications on the medicinal functional nonwoven fabric of human body at Nonimplantation, is applied to go back preventable disease simultaneously body surface, the membrane disease except that being made into various antiseptic dressings; In addition, more extensive on the various antibacterial products Application and Development of human lives, work, as be made into various antibiotic clothes, bedding, socks footwear or the like textiles, light industrial goods and hospital equipment etc.We can say that the application of Nano Silver will make the human lives that the raising of a matter be arranged, nano-silver nonwoven cloth will start one and take turns new Industrial Revolution, will promote shooting up and developing of medicinal functional nonwoven fabric industry.
Antibacterial flexible material containing nm silver of the present invention (with the nonwoven fabric is example, and code name is WFB) is through test, and every index is as follows:
1, long-lasting:
Make extracorporeal bacteria inhibitor test with the WFB original without any processing through following 3 kinds of modes again after handling, the result confirms that treated WFB and its fungistatic effect of WFB original are constant substantially.
(1) washing is 50 times, washes clear water rinsing, totally 50 times by rubbing with the hands with soap is manual at every turn;
(2) washing is 100 times, only washes by rubbing with the hands totally 100 times with cleaning at every turn;
(3) WFB steeps (changing water every day) through 45 days water logging.
2, broad spectrum activity:
(1) extracorporeal bacteria inhibitor test of WFB:
WFB is carried out MH flat board (or Colombia's agar plate or blood plate) extracorporeal bacteria inhibitor test, and identification of strains and drug sensitive test are with the French Vitek-32 of Biomerieux SA microorganism fully-automatic analyzer.Test specimen comprises the WFB original of not doing any processing and the WFB that handles through aforementioned (1), (2).The bacterial classification of extracorporeal bacteria inhibitor test comprises that gram-positive bacteria, Gram-negative bacteria, fungi and brood cell etc. amount to more than 40 pathogenic species.The result proves that WFB shows obvious bacteria resistance function to these more than 40 bacterial classifications, and these more than 40 bacterial classifications remove that a few is arranged is the international standard bacterial strain, and great majority are bacterial strains of separating from patient's secretion, and its antibacterial difficulty is bigger.
Above extracorporeal bacteria inhibitor test is to be detected by prominent domestic units such as medicine test center Microbiological Labs of the entire PLA of the Chinese People's Liberation Army.
The antibacterial result of WFB antimicrobial yarn and 8 kinds of antibacterials
WFB antimicrobial yarn and control group bacteriostatic diameter antibacterials WIC method drug sensitivity tests
In the big ring of the negative benzene azoles ammonia benzyl cephalo cephalo cephalo celebrating of bacterium name source washing washing
Do not wash erythromycin
The 50 times 100 times husky stars of contrast XiLin, XiLin his pyridine mycin of azoles quinoline furan oxime
Staphylococcus aureus ATCC25923 20 18 18 7 24 S S S S S S S
Escherichia coli ATCC25922 15 14 14 7 10 S S S S S S
Pseudomonas aeruginosa ATCC27853 13 12 12 76 S S S
C.perfringens CMCC (B) 64,606 10
Staphylococcus aureus (MRSE) secretion 19 17 17 76 R R R R R R R
Staphylococcus epidermidis (MRSE) secretion 20 17 17 76 R R R R R R R
Micrococcus scarlatinae secretion 11 8876 S S S S S S S
Diplococcus gonorrhoeae secretion 11 10 10 7 31 S S S S S S
Escherichia coli secretion 17 15 15 76 R R R R R R
Enterobacter cloacae secretion 10 887 11 R R R R R R
Clostridium perfringen secretion 15 13 13 76 R R R R R R
Pseudomonas aeruginosa secretion 17 15 15 76 R R R R R R
Stenotrophomonas maltophilia secretion 16 13 14 76 R R R S R S
Acinetobacter bauamnnii secretion 15 12 12 7 19 R R R S S S
Klebsiella Pneumoniae secretion 17 14 14 76 R R R S R S
Serratia marcesens secretion 18 13 14 76 R R R R R S
Take labor ground citrobacter secretion 13 10 10 76 R R R R R R
Thunder amasss Pu Luoweideng bacterium secretion 15 13 13 76 R R R S R S
Aeromonas hydrophila secretion 13 11 13 7 16 R R R S R S
Aeromonas sobria secretion 14 12 12 7 17 R I I S R S
Vibrio vulnificus secretion 19 17 17 76 R R R S I S
Proteus mirabilis secretion 13 11 11 79 R R R S R R
Proteus vulgaris secretion 12 10 11 76 R R R S R R
Pan Shi proteus secretion 11 10 10 76 R R I S R S
Candida albicans secretion 23 21 21 76
Candida tropicalis secretion 20 17 17 76
Candida parapsilosis secretion 21 20 20 76
Torulopsis glabrata secretion 28 27 27 76
Annotate: S: responsive I: the R of intermediary: resistance
2, WFB has excellent bacteriostasis property to the drug resistance pathogenic bacteria
WFB and 8 antibacterials are made extracorporeal bacteria inhibitor test to 28 pathogenic bacteria simultaneously, the result shows that WFB all shows tangible bacteria resistance function to 28 bacterial classifications, erythromycin only has bacteria resistance function to 8 bacterial classifications, Oxacillin (2), ampicillin (4), cephazoline (4), Zinacef (4), cefotaxime (15), gentamicin (6), Ciprofloxacin (14).
The extracorporeal bacteria inhibitor test that experimental results show that WFB and these 8 antibacterials compares, and the bacteria resistance function that WFB has a clear superiority in to chemical sproof bacterial classification is described.
4, pharmacokinetic
With cavy and rabbit is subjects, and WFB is to skin acute toxicity test, irritant test, hypersensitive test.Test unit: hospital general's pharmacology section of Nanjing Military Command.Result of the test proof WFB avirulence, nonirritant, no anaphylaxis.
5, clinical verification
Carried out clinical verification through after the above-mentioned test, existing existing:
(1) 50 clinical reports that a burn case of hospital general, Chinese People's Liberation Army Nanjing Burn and Plastic Surgery Dept. work.
(2) clinical report of the II class otch clinical follow of Jiangsu Prov. People's Hospital department of general surgery work.
(3) clinical report of the superficial skin fungus of Inst. of Dermatology, Chinese Academy of Medical Sciences's work.
Also have hospital of a few family that clinical testings such as skin-grafting area, tumour otch clinical follow, burn and scald, skin ulcer observation are carried out in addition.
Below further specify the present invention by specific embodiment, but embodiment only be used for the explanation, can not limit the scope of the invention.
In the present invention, if not refer in particular to, all parts, amount are the unit of weight based on gross weight.
Example 1
Take by weighing 7 kilograms of silver nitrates, be dissolved in 380 premium on currency, add 26 liters of concentrated ammonia liquors, adding water, to make its volume be 1000 liters, and mix; The degreasing all cotton non-woven fabric that purchase is obtained fully soaks into padding finishing liquid, and pick-up rate is 60%; Roll nonwoven fabric after doing and enter that use hot air circulation drying, time in the drying case be 4 minutes, temperature is 130 ℃, and guarantees the oxygen of abundance; At last the nonwoven fabric behind drying is cut into the size that needs, sprays the distilled water of fabric weight 50% after the sterilization, airtight package.
Example 2
Take by weighing 18 kilograms of silver nitrates, be dissolved in 600 premium on currency, add 33 liters of concentrated ammonia liquors, adding water, to make its volume be 1000 liters, and mix.The degreasing all cotton non-woven fabric that purchase is obtained fully soaks into padding finishing liquid, and pick-up rate is 80%; Roll nonwoven fabric after doing and enter that use hot air circulation drying, time in the drying case be 3 minutes, temperature is 160 ℃, and guarantees the oxygen of abundance; At last the nonwoven fabric behind drying is cut into the size that needs, sprays the distilled water of fabric weight 60% after the sterilization, airtight package.
Example 3
Take by weighing 13 kilograms of silver nitrates, be dissolved in 530 premium on currency, add 22 liters of concentrated ammonia liquors, get 2.8 kilograms of glucose, be dissolved in 100 premium on currency, adding water, to make its volume be 1000 liters, and mix, and all the other methods are with example 1.
Example 4
Take by weighing 30 kilograms of silver nitrates, be dissolved in 800 premium on currency, add 37 liters of concentrated ammonia liquors, get 4.8 kilograms of glucose, be dissolved in 100 premium on currency, add 0.25 liter of red fuming nitric acid (RFNA) again, 0.9 kilogram in NaOH, adding water, to make its volume be 1000 liters, and mix, all the other methods are with example 2.
Example 5
Take by weighing 10 kilograms of silver nitrates, be dissolved in 350 premium on currency, add 14 liters of concentrated ammonia liquors, get 0.6 kilogram of glucose, be dissolved in 50 premium on currency, add 0.35 liter of red fuming nitric acid (RFNA) again, 1.8 kilograms in NaOH, adding water, to make its volume be 1000 liters, and mix, all the other methods are with example 2.
Example 6
Take by weighing 15 kilograms of silver nitrates, be dissolved in 580 premium on currency, add 36 liters of concentrated ammonia liquors, adding water, to make its volume be 1000 liters, and mix; The paper that purchase is obtained fully soaks into padding finishing liquid, and pick-up rate is 60%, and the paper behind the mangle enters and uses the hot air circulation drying in the drying case, time is 2 minutes, and temperature is 80 ℃, and guarantees sufficient oxygen, at last the paper behind drying is cut into the size that needs, sterilization back airtight package.
Example 7
Take by weighing 8 kilograms of silver nitrates, be dissolved in 400 premium on currency, add 18 liters of concentrated ammonia liquors, adding water, to make its volume be 1000 liters, and mix; The paper substrate nonwoven fabric that purchase is obtained fully soaks into padding finishing liquid, pick-up rate is 80%, paper behind the mangle enters and uses the hot air circulation drying in the drying case, time is 3 minutes, temperature is 80 ℃, and guarantees sufficient oxygen, at last the paper behind drying is cut into the size that needs, spray the thimerosal of paper substrate nonwoven fabric weight 60% after the sterilization, airtight package.
Example 8
The concentration of spraying paper substrate nonwoven fabric weight 60% after sterilization is that all the other are with example 8 75% the ethanol.
Example 9
Except that adopting the polyster fibre based nonwoven, all the other are with example 1.
Example 10
Take by weighing 28 kilograms of silver nitrates, be dissolved in 800 premium on currency, add 38 liters of concentrated ammonia liquors, adding water, to make its volume be 1000 liters, and mix; Purchase is obtained zeolite grind, make its particle diameter less than 30 microns, fully soak into dressing liquid then, entering afterwards again and using hot air circulation drying, time in the drying case is 6 minutes, and temperature is 160 ℃, and guarantees sufficient oxygen, airtight package.
Example 11
Take by weighing 10 kilograms of silver nitrates, be dissolved in 520 premium on currency, add 36 liters of concentrated ammonia liquors, adding water, to make its volume be 1000 liters, and mix; The degreasing all cotton fabric that purchase is obtained fully soaks into padding finishing liquid, and pick-up rate is 60%; Roll degreasing all cotton fabric after doing and enter that use hot air circulation drying, time in the drying case be 4 minutes, temperature is 130 ℃, and guarantees the oxygen of abundance; At last the degreasing all cotton fabric behind drying is cut into the size that needs, sprays the distilled water of fabric weight 40% after the sterilization, airtight package.
Claims (5)
1, a kind of preparation method of antibacterial flexible material containing nm silver, it is characterized in that comprising padding finishing liquid, roll steps such as dried, drying, described padding finishing liquid comprises that flexible material with marshalling in deflector roll is immersed in treatment fluid, keeps the liquid level certain height, and flexible material is fully soaked into; Described to roll dried pick-up rate be 40～90%, uses the hot air circulation drying then under air blast and exhausting condition, and the time is 1～6 minute, and temperature is 90～180 ℃, and guarantee sufficient oxygen, and described dressing liquid prescription is: (in 200 kilograms of flexible materials):
4～32 kilograms of silver nitrates, 12～45 liters of ammoniacal liquor,
1～25 kilogram of glucose adds water to 1000 liters.
2, a kind of preparation method of antibacterial flexible material containing nm silver, it is characterized in that comprising padding finishing liquid, roll steps such as dried, drying, described padding finishing liquid comprises that flexible material with marshalling in deflector roll is immersed in treatment fluid, keeps the liquid level certain height, and flexible material is fully soaked into; Described to roll dried pick-up rate be 40～90%, uses the hot air circulation drying then under air blast and exhausting condition, and the time is 1～6 minute, and temperature is 90～180 ℃, and guarantee sufficient oxygen, and described dressing liquid prescription is: (in 200 kilograms of flexible materials):
4～32 kilograms of silver nitrates, 12～45 liters of ammoniacal liquor,
0.6～3.2 kilogram in NaOH, 0.2～11 kilogram of glucose,
0.1～0.6 liter in nitric acid, surplus are that water amounts to 1000 liters.
3, the preparation method of antibacterial flexible material containing nm silver according to claim 1 and 2 is characterized in that described flexible material is a bondedfibre fabric.
4, the preparation method of antibacterial flexible material containing nm silver according to claim 3 is characterized in that also being included in drying, makes the step that adds liquid behind the product, and the amount of liquid of adding is 20～200% of a bondedfibre fabric weight.
5, the preparation method of antibacterial flexible material containing nm silver according to claim 3 is characterized in that described liquid is the mixture of water, organic solvent and water and organic solvent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB01102268XA CN1159488C (en) | 2001-01-20 | 2001-01-20 | Antibacterial flexible material containing nm silver and its preparing process and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB01102268XA CN1159488C (en) | 2001-01-20 | 2001-01-20 | Antibacterial flexible material containing nm silver and its preparing process and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1306117A CN1306117A (en) | 2001-08-01 |
| CN1159488C true CN1159488C (en) | 2004-07-28 |
Family
ID=4652606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB01102268XA Expired - Lifetime CN1159488C (en) | 2001-01-20 | 2001-01-20 | Antibacterial flexible material containing nm silver and its preparing process and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1159488C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022099827A1 (en) * | 2020-11-12 | 2022-05-19 | 上海普榭尔科技有限公司 | Method for preparing antimicrobial treatment agent for textile |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
| US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
| US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
| US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
| US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
| EP1303283B1 (en) | 2000-07-27 | 2004-11-17 | Nucryst Pharmaceuticals Corp. | Use of noble metals for the manufacture of a medicament to treat hyperproliferative skin disorders and diseases |
| US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| US20030185901A1 (en) | 2000-07-27 | 2003-10-02 | Burrell Robert E. | Methods of treating conditions with a metal-containing material |
| US7255881B2 (en) | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
| WO2002085384A2 (en) | 2001-04-23 | 2002-10-31 | Nucryst Pharmaceuticals Corp. | Lubricious coatings for substrates |
| US7048771B2 (en) * | 2001-10-22 | 2006-05-23 | University Of California | Dyeing textiles using nanoparticles |
| US6979491B2 (en) * | 2002-03-27 | 2005-12-27 | Cc Technology Investment Co., Ltd. | Antimicrobial yarn having nanosilver particles and methods for manufacturing the same |
| US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
| CN2734238Y (en) * | 2004-08-25 | 2005-10-19 | 任晓艳 | Nano silver coated suture line |
| US8865227B2 (en) | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
| CN101585088B (en) * | 2008-05-21 | 2011-07-27 | 任晓艳 | Method for preparing nano-silver thread |
| CN103640274A (en) * | 2013-11-26 | 2014-03-19 | 大连创达技术交易市场有限公司 | Textile method of antioxidant material |
| CN104821210B (en) * | 2015-05-15 | 2017-04-05 | 浙江农林大学 | A kind of preparation method of cellulose base conductive material |
| US20230149454A1 (en) * | 2020-08-04 | 2023-05-18 | Kuprion Inc. | Antiseptic applications of metal nanoparticle agglomerates |
-
2001
- 2001-01-20 CN CNB01102268XA patent/CN1159488C/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022099827A1 (en) * | 2020-11-12 | 2022-05-19 | 上海普榭尔科技有限公司 | Method for preparing antimicrobial treatment agent for textile |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1306117A (en) | 2001-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1159488C (en) | Antibacterial flexible material containing nm silver and its preparing process and application | |
| CN1147640C (en) | Antibacterial fabric containing nm-class silver powder and its making method | |
| CN1161511C (en) | Long-acting wide-spectrum antiseptic nanometer silver fabric and its making method | |
| CN1179646C (en) | Aggregation-preventing nanometer wide-spectrum antibacterial silve powder and its inductrial production process | |
| US6379712B1 (en) | Nanosilver-containing antibacterial and antifungal granules and methods for preparing and using the same | |
| CN1643206A (en) | Antimicrobial yarn having nanosilver particles and methods for manufacturing the same | |
| WO2016206638A1 (en) | Wound dressing containing silver chelate fiber | |
| CN101400379A (en) | Methods for producing silver-bonded antimicrobial moist wound dressings and moist wound dressings produced by the methods | |
| CN1429297A (en) | Methods and fabrics for combating nosocomial infections | |
| CN1772311A (en) | Wound dressing containing Ag-Zn composition | |
| CN107254742B (en) | The composite fiber web of polyvinyl alcohol/sericin containing nano silver for medical dressing | |
| CN107326470A (en) | A kind of processing method of the lasting modified polyester fiber of antibacterial | |
| CN1034090C (en) | Long-acting broad-spectrum antiseptic fabric and its producing method | |
| US9723843B2 (en) | Family of silver (I) periodate compounds having broad microbial properties | |
| CN1183285C (en) | Aggregation-preventing wide-spectrum nanometer antibiotic silver yarn and its industrial production process | |
| CN100334292C (en) | Nanometer silver antiseptic yarn and its production process | |
| Hajimirzababa et al. | Modified cotton gauze with nano-Ag decorated alginate microcapsules and chitosan loaded with PVP-I | |
| CN104204340A (en) | Anti-microbial textiles | |
| CN1720801A (en) | Silver carried bactericidal active carbon, its preparation process and application | |
| CN1379146A (en) | Anticoagulation antibacterial non-woven cloth containing nano silver (Ag+Ag2O) and its industrial production technology | |
| CN108468098A (en) | Antibacterial textile fabric, antibacterial textile fabric and antibacterial textile fabric preparation method | |
| CN109706731B (en) | Bi-component antibacterial cellulose material and preparation method and application thereof | |
| CN1473553A (en) | Anti-coagulation nano silver antibiotic dressing | |
| CN1723778A (en) | Silver-contg. type antibiotic agent, prepn. method and application thereof | |
| CN1156624C (en) | Aggregation-preventing wide-spectrum antiseptic nanometer silver knitted article and fabric and their industrial production process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20040714 Pledge (preservation): Preservation |
|
| PD01 | Discharge of preservation of patent |
Effective date of registration: 20050114 Pledge (preservation): Preservation |
|
| ASS | Succession or assignment of patent right |
Owner name: NANJING XIKE NANO MEDICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: XIKE GROUP CO LTD, NANJING Effective date: 20050729 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20050729 Address after: 210009 No. 79 Yunnan North Road, Nanjing, Jiangsu Patentee after: Nanjing Xike Group Corp., Ltd. Address before: 210009 No. 79 Yunnan North Road, Nanjing, Jiangsu Patentee before: Xike Group Co., Ltd., Nanjing |
|
| PP01 | Preservation of patent right |
Effective date of registration: 20050808 Pledge (preservation): Preservation |
|
| PD01 | Discharge of preservation of patent |
Date of registration: 20061019 Pledge (preservation): Preservation |
|
| C56 | Change in the name or address of the patentee |
Owner name: NANJING GOLDLANDSW MEDICAL SCIENCE + TECHNOLOGY CO Free format text: FORMER NAME: NANJING XIKE NANO-MEDICAL TECHNOLOGY CO., LTD. |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 210009 No. 79 Yunnan North Road, Nanjing, Jiangsu Patentee after: Nanjing Jindi Puhui Medical Technology Co., Ltd. Address before: 210009 No. 79 Yunnan North Road, Nanjing, Jiangsu Patentee before: Nanjing Xike Group Corp., Ltd. |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20040728 |